Biomedical and Biotechnology Research Journal (BBRJ)
About the Journal
Biomedical and Biotechnology Research Journal (BBRJ), a publication of Society of Biomedical & Biotechnology Scientists (https://www.sbbs-soc.com), is a peer-reviewed online journal with print on demand compilation of issues published. The BBRJ aims to publish current research related to biological and medical studies of biotechnology. It aims to promote communication among clinical researchers, physicians and biologist that works in areas related to Biotechnology, worldwide. The scope of “Biomedical and Biotechnology Research Journal (BBRJ) includes:
- Basics studies on Nano biotechnology
- Basics studies on Tissue Engineering
- Basics studies on Genetics
- Basics studies on Tissue Modeling
- Basics studies on Immunology
- Basics studies on Infectious Diseases
- Nucleic Acids/Molecular Biology
- Biochemical Engineering/Bioprocess Engineering
- Computational Chemistry and Molecular Drug Design
- Genomics and Molecular Bioinformatics
- Biomarkers Studies
The journal’s full text is available online at http://www.bmbtrj.org. The journal allows free access (Open Access) to its contents and permits authors to self-archive final accepted version of the articles on any OAI-compliant institutional / subject-based repository.
Abstracting and Indexing Information
The journal is registered with the following abstracting partners:
Baidu Scholar, CNKI (China National Knowledge Infrastructure), EBSCO Publishing’s Electronic Databases, Exlibris – Primo Central, Google Scholar, Hinari, Infotrieve, ProQuest, TdNet
Wolters Kluwer and Journal/Association are committed to meeting and upholding standards of ethical behavior at all stages of the publication process. We follow closely the industry associations, such as the Committee on Publication Ethics (COPE), International Committee of Medical Journal Editors (ICMJE) and World Association of Medical Editors (WAME), that set standards and provide guidelines for best practices in order to meet these requirements. For a summary of our specific policies regarding duplicate publication, conflicts of interest, patient consent, etc., please visit www.Medknow.com/EthicalGuidelines.asp
Open Access Publication and Creative Commons Licensing
This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
Wolters Kluwer Medknow provides for long-term digital preservation through two primary partnerships, Portico and CLOCKSS.
Portico is a leading digital preservation service worldwide. The content is preserved as an archival version and is not publically accessible via Portico, but is provided when required under specific conditions, such as discontinuation of the collection or catastrophic failure of the website.
CLOCKSS will enable any library to maintain their own archive of content from Wolters Kluwer Medknow and other publishers, with minimal technical effort and using cheaply available hardware.
Ahead of Print policy
Articles published online under the Ahead of Print model are considered published and can be cited and quoted using the DOI as the reference source. Wolters Kluwer Medknow has a policy that changes will not be made after publication of an article without following accepted procedures for making corrections to the scientific record.
While advertisements are crucial to this journal to be able to keep all content free for everyone, ethical considerations are in place to ensure the integrity of the journal and its content:
- “Pop-up” and “banner” ads appear on a random, rotating basis. The advertiser has no control or input over the pages where their ads appear.
- The Editorial Board has full and final approval over the content of all advertisements.
- Advertisers will never be shown any manuscripts or other content prior to publication.
About the Society
Established by Society of Biomedical and Biotechnology Scientists in 2006.The Society of Biomedical and Biotechnology Scientists (SBBS) is non-profit federation of international Biomedical and Biotechnology Associations, witch consist of learned Societies, universities, scientific institutes, biotech Companies and individual bio technologists whom are working to promote biomedical and biotechnology throughout the world with special references to Asian –countries. The mission of SBBS is to promote the safe, sustainable and beneficial use of the life sciences, to promote research and innovation of biomedical & biotechnology, to provide a forum for interdisciplinary and international cooperation, to improve scientific education and to facilitate an informed dialogue between scientists and the public.
The SBBS Central Office (SBBS-Co) is located in Mycobacteriology Research Center, National Research Institute of Tuberculosis and Lung Disease (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Membership, Journal, international congress administration, organization of executive board meetings and general assemblies, website management (www.sbbs-soc.com) are some of the main responsibilities of SBBS-Co
Scope of the journal
The journal will cover technical and clinical studies related to health, ethical and social issues in field of Nucleic Acids/Molecular Biology, Physiology/Biochemistry, Biochemical Engineering/Bioprocess Engineering, Computational Chemistry and Molecular Drug Design, Genomics and molecular Bioinformatics, Biomarkers studies, Basics studies on tissue modeling, Proteomics. Articles with clinical interest and implications will be given preference.
Medknow, part of Wolters Kluwer Health, is one of the largest open access publishers worldwide with more than 300+ medical journals in its portfolio. Students, researchers, clinicians and other healthcare professionals worldwide access Medknow journals to help them fuel new discoveries and improve patient care.
Founded in 1997, Medknow is a well-respected medical publisher that fully supports many of the popular open access models through its peer-review management system. Medknow pioneers in the ‘fee-less-free’ model and provides immediate free access to the electronic editions of the journals without charging the author or author’s institution for submission, processing or publication of the articles. Medknow’s open access policy has resulted in more than a half a million article downloads monthly for all of its journals.
Wolters Kluwer Health (Philadelphia, PA) is a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Serving more than 150 countries and territories worldwide, Wolters Kluwer Health’s customers include professionals, institutions and students in medicine, nursing, allied health and pharmacy. Major brands include Lippincott Williams & Wilkins, Ovid®, UpToDate®, Medi-Span®, Facts & Comparisons®, Pharmacy OneSource®, Lexicomp® and ProVation® Medical. Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global information services company with annual revenues (2011) of €3.4 billion ($4.7 billion), approximately 19,000 employees worldwide and operations in over 40 countries across Europe, North America, Asia Pacific, and Latin America.
Online and Print Scholarly Publishing, Peer-Review System, Specialized in Medical Research, Largest Open Access Publisher